Home » Stocks » HCAT

Health Catalyst, Inc. (HCAT)

Stock Price: $48.53 USD 0.94 (1.98%)
Updated Jan 21, 2021 1:36 PM EST - Market open
Market Cap 2.02B
Revenue (ttm) 179.07M
Net Income (ttm) -86.27M
Shares Out 40.29M
EPS (ttm) -28.31
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 21
Last Price $48.53
Previous Close $47.59
Change ($) 0.94
Change (%) 1.98%
Day's Open 47.48
Day's Range 47.01 - 48.92
Day's Volume 211,487
52-Week Range 17.80 - 48.92

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
Kiplinger - 6 days ago

If you desire growth, then your sights should be set on small-cap stocks. These 11 have attracted the gaze of dozens of Wall Street's best minds.

Other stocks mentioned: BJ, FATE, GLNG, GTLS, IIVI, LPSN, NVRO, PDCE, PZZA, QTS
PRNewsWire - 1 week ago

SALT LAKE CITY, Jan. 11, 2021 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizati...

GlobeNewsWire - 4 weeks ago

SALT LAKE CITY, Dec. 22, 2020 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organi...

Seeking Alpha - 1 month ago

US healthcare costs have ballooned in recent years, yet at least 25% of that spending is due to general inefficiency. Health Catalyst provides a way for healthcare organizations to manage thei...

Zacks Investment Research - 1 month ago

Health Catalyst (HCAT) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.

GlobeNewsWire - 1 month ago

SALT LAKE CITY, Nov. 24, 2020 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organi...

Seeking Alpha - 2 months ago

Health Catalyst, Inc. (HCAT) CEO Dan Burton on Q3 2020 Results - Earnings Call Transcript

Zacks Investment Research - 2 months ago

Health Catalyst (HCAT) delivered earnings and revenue surprises of 22.22% and 5.69%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the st...

Benzinga - 2 months ago

Shares of Health Catalyst (NASDAQ:HCAT) rose 2.39% in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share rose 22.22% over the past year to ($0.21)...

GlobeNewsWire - 2 months ago

SALT LAKE CITY, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today repo...

GlobeNewsWire - 2 months ago

Announces Promotion of Bryan Hunt as CFO and Additional Leadership Responsibilities to Support Continued Growth and Expansion Announces Promotion of Bryan Hunt as CFO and Additional Leadership...

Zacks Investment Research - 2 months ago

Health Catalyst (HCAT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

GlobeNewsWire - 2 months ago

SALT LAKE CITY, Nov. 02, 2020 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organi...

GlobeNewsWire - 2 months ago

SALT LAKE CITY, Oct. 26, 2020 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organi...

PRNewsWire - 2 months ago

SALT LAKE CITY, Oct. 22, 2020 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizati...

InvestorPlace - 3 months ago

As data is becoming more vital to healthcare, investors should consider buying "big data" stocks with high exposure to the sector. The post 3 Big Data Stocks Making Healthcare Better appeared ...

Other stocks mentioned: MDLA, SPLK
The Motley Fool - 3 months ago

Yes, it's a leader with lots of momentum. But you need to understand this one key difference.

Seeking Alpha - 4 months ago

Health Catalyst - Looks Cheap But Where Is The Catalyst?

Seeking Alpha - 5 months ago

Health Catalyst, Inc. (HCAT) CEO Dan Burton on Q2 2020 Results - Earnings Call Transcript

Benzinga - 5 months ago

Shares of Health Catalyst (NASDAQ:HCAT) fell 8.31% in after-market trading after the company reported Q2 results.

Zacks Investment Research - 5 months ago

Health Catalyst (HCAT) delivered earnings and revenue surprises of 37.50% and 3.24%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

GlobeNewsWire - 5 months ago

SALT LAKE CITY, Aug. 11, 2020 (GLOBE NEWSWIRE) -- Health Catalyst, Inc.  (“Health Catalyst,” Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare or...

GlobeNewsWire - 5 months ago

SALT LAKE CITY, Aug. 11, 2020 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today re...

GlobeNewsWire - 5 months ago

SALT LAKE CITY, Aug. 10, 2020 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare orga...

Zacks Investment Research - 5 months ago

Health Catalyst (HCAT) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Zacks Investment Research - 5 months ago

Health Catalyst (HCAT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research - 5 months ago

Here we discuss three medical product stocks that are due to report soon and are likely to beat estimates on earnings, riding on a host of factors.

Other stocks mentioned: TMDX, RMD
GlobeNewsWire - 5 months ago

SALT LAKE CITY, July 29, 2020 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare orga...

PRNewsWire - 5 months ago

SALT LAKE CITY, July 28, 2020 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizati...

Zacks Investment Research - 5 months ago

As of late, it has definitely been a great time to be an investor in Health Catalyst.

GlobeNewsWire - 6 months ago

SALT LAKE CITY, July 09, 2020 (GLOBE NEWSWIRE) -- Health Catalyst, Inc.  (“Health Catalyst,” Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare or...

The Motley Fool - 6 months ago

Big data is becoming a big factor in the healthcare industry.

Other stocks mentioned: CERN, GMED
Seeking Alpha - 7 months ago

Health Catalyst reported the results of its fiscal Q1 (ended 3/31) last week.

Seeking Alpha - 7 months ago

Health Catalyst - Helping Health Care Providers Manage Through The Covid-19 Crisis

Zacks Investment Research - 8 months ago

Medical Info Systems Outlook Bright Amid Coronavirus Crisis

Other stocks mentioned: CERN, DGX, HUM, ONEM, UNH
Seeking Alpha - 8 months ago

Health Catalyst, Inc. (HCAT) CEO Dan Burton on Q1 2020 Results - Earnings Call Transcript

GlobeNewsWire - 8 months ago

SALT LAKE CITY, May 12, 2020 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today rep...

GlobeNewsWire - 8 months ago

SALT LAKE CITY, May 12, 2020 (GLOBE NEWSWIRE) -- The board of directors (the “Board”) of Health Catalyst, Inc. ("Health Catalyst,” Nasdaq:  HCAT ), a leading provider of data and analytics...

Zacks Investment Research - 8 months ago

Health Catalyst (HCAT) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Zacks Investment Research - 8 months ago

Despite the negative earnings trend, a handful of stocks with a favorable Zacks Rank are poised to beat earnings estimates this week.

Other stocks mentioned: GO, LOGI, SSRM, VIE
Seeking Alpha - 8 months ago

Health Catalyst Prepares For Pandemic Sales Slowdown

InvestorPlace - 8 months ago

These small-cap stocks could rise by 1,000% or more in the 2020s, making them some of the best stocks to buy for the next 10 years.

Other stocks mentioned: CDLX, INMD, INSG, LPSN, MAXR, NIO, PLUG, SFIX, TRHC
GlobeNewsWire - 9 months ago

SALT LAKE CITY, April 09, 2020 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (Nasdaq: HCAT) (the “Company” or “Health Catalyst”) announced today the pricing of $200.0 million aggregate principal...

GlobeNewsWire - 9 months ago

SALT LAKE CITY, April 08, 2020 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (Nasdaq: HCAT) (the “Company” or “Health Catalyst”) announced today that it intends to offer, subject to market condi...

InvestorPlace - 9 months ago

Healthcare stocks are in the spotlight as the coronavirus brings to light the importance of collecting data and using it to predict outcomes.

Other stocks mentioned: GMED, TDOC
Zacks Investment Research - 9 months ago

Health Catalyst (HCAT) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.

Seeking Alpha - 10 months ago

Health Catalyst, Inc. (HCAT) CEO Daniel Burton on Q4 2019 Results - Earnings Call Transcript

GlobeNewsWire - 11 months ago

SALT LAKE CITY, Feb. 18, 2020 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare orga...

Zacks Investment Research - 1 year ago

As of late, it has definitely been a great time to be an investor Health Catalyst.

InvestorPlace - 1 year ago

Given the renewed sense of optimism that has found its way to Wall Street, these strong buy stocks won't be bargains for very long.

Other stocks mentioned: ASUR, NXST, PAYS, VNOM, WPX, WWE

About HCAT

Health Catalyst provides data and analytics technology and services to healthcare organizations. Its solutions include a cloud-based data platform, analytics software, and professional services. The company was founded in 2008 and is headquartered in Salt Lake City, Utah.

Industry
Health Information Services
IPO Date
Jul 25, 2019
CEO
Daniel D. Burton
Employees
1,000
Stock Exchange
NASDAQ
Ticker Symbol
HCAT
Full Company Profile

Financial Performance

In 2019, HCAT's revenue was $154.94 million, an increase of 37.63% compared to the previous year's $112.57 million. Losses were -$60.10 million, -3.05% less than in 2018.

Financial Statements

Analyst Forecasts

According to 14 analysts, the average rating for HCAT stock is "Strong Buy." The 12-month stock price forecast is 44.85, which is a decrease of -7.58% from the latest price.

Price Target
$44.85
(-7.58% downside)
Analyst Consensus: Strong Buy